Labcorp Launches H5 Bird Flu Test
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Covid 19, Immunoassay Reagents & test Kits |
The TaqPath COVID-19 Diagnostic PCR Kit enables labs to adopt a validated in vitro diagnostic workflow for SARS-CoV-2 detection.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Diagnostic Technologies |
Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.
Read MorePosted by Andy Lundin | Dec 2, 2024 | Company News |
QIAGEN is relocating its QIAstat-Dx operations to a new facility in Barcelona to strengthen its syndromic testing capabilities.
Read MorePosted by Chris Wolski | Nov 28, 2024 | Diagnostic Technologies |
Chronic fatigue syndrome (CFS) is a complex illness characterized by extreme fatigue that doesn’t improve with rest.
Read More